Experience with Liposomal Amphotericin B in Outpatient Parenteral Antimicrobial Therapy.

Burnett, Yvonne J; Spec, Andrej; Ahmed, Mohamed M; Powderly, William G; Hamad, Yasir

Burnett, Yvonne J; Spec, Andrej; Ahmed, Mohamed M; Powderly, William G; Hamad, Yasir.

Afiliação

Burnett YJ; Department of Pharmacy Practice, St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis, St. Louis, Missouri, USA Yvonne.burnett@uhsp.edu.
Spec A; Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Ahmed MM; Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Powderly WG; Department of Nephrology, Medical University of South Carolina, Charleston, South Carolina, USA.
Hamad Y; Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

Antimicrob Agents Chemother ; 65(6)2021 05 18.

Article em En | MEDLINE | ID: mdl-33846129

Assuntos

Anti-Infecciosos; Pacientes Ambulatoriais; Anfotericina B; Antifúngicos/efeitos adversos; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos

Palavras-chave

OPAT; amphotericin; hypokalemia; nephrotoxicity; outpatient

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pacientes Ambulatoriais / Anti-Infecciosos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google